Gwen Wong Named "Future Leader" for IPOs in China by IFLR
June 30, 2021Gwen Wong has been named a “Future Leader” by IFLR, recognizing her work on some of China’s biggest and most complex IPOs. Gwen is the exclusive international lawyer to receive a commendation in this category in the inaugural Asia Future Leaders guide. The award recognizes exceptional individual practitioners who have displayed leadership attributes in their field and whom received the highest praise from their peers and clients in their relevant jurisdictions over the past year.
Gwen’s recent IPO representations include acting as Hong Kong and U.S. counsel to:
- joint sponsors and joint financial advisers to Haier Smart Home in its simultaneous listing by way of an introduction on the Stock Exchange of Hong Kong Limited (SEHK) and privatization of Haier Electronics Group by way of a scheme of arrangement
- the sole sponsor and underwriters in JOINN Laboratories’ $839 million initial public offering and listing on the SEHK
- the joint sponsors and underwriters in Hepalink’s $523 million initial public offering and listing on the SEHK
- the joint sponsors and underwriters in Zhaoke Ophthalmology Limited’s $267 million initial public offering and spin-off listing on the SEHK
- the joint sponsors and underwriters in New Horizon Health Limited’s $263 million initial public offering and listing on the SEHK
- the joint sponsors and underwriters in Jacobio Pharmaceuticals’ $174 million initial public offering and listing on the SEHK
- the sole sponsor in South China Vocational Education Group’s initial public offering and listing on the SEHK